“a decreasing trend”

A significant decrease and a decreasing trend occurred at T3, respectively, in PC3 ( p = 0.0179) and DC3 ( p = 0.0506), which may reflect a transient action of the phage.

Lumbar spine T-scores also showed a decreasing trend (−1.95 ± 0.74 vs −2.22 ± 0.69 vs −2.51 ± 0.70, F = 4.21, P = .018, P for trend = .008).

No significant difference was observed in the proportion of lower limb osteoarticular involvement across different age groups ( P = 0.055), but there was a decreasing trend noted as age increased ( P = 0.018) ( Figure 3a ).

A decreasing trend of the age-standardized rate was also seen in both sexes (males: AAPC =−5.18%, P = 0.019; females: AAPC =−3.34%, P = 0.046).

In decompensated patients, we observed a decreasing trend from ALD, through to MASLD and other etiologies: 19.0, 15.5, and 14.0 mmHg (P = 0.019) ( Fig 2B ).

Meta-regression revealed a dose–response relationship only between volume and 6MWT, with a decreasing trend ( P = 0.019, 95% CI − 1.63 to − 0.20).

This indicates a decreasing trend in the detection rate of normal karyotypes with increasing maternal age, with Cochran-Armitage trend test results of z = -2.3414 and p- value = 0.01921.

In the c POA groups, a decreasing trend in body weight was observed starting from the second week, with the C-H group showing a significant reduction ( p = 0.0194).

The content of pyruvic acid significantly decreased ( p = 0.045), the content of DL-3-phenyllactic acid also showed a decreasing trend ( p = 0.020), L-Cystine increased ( p = 0.009), and glutamine significantly increased ( p < 0.001).

A decreasing trend was observed in the number of prematurity screenings for ROP ( P = 0.02).

A decreasing trend of glomerular impairment events (5.6%, 5.5%, 4.4%, and 4.1% from waves 1 to 4, respectively; Z = −2.4, p = 0.02) was seen with an overall rate of 4.9% for the total person-visits in this general pediatric population.

The age‐adjusted incidence rate of COPD among adults aged 50 and over showed a decreasing trend throughout the study period 1031.1 per 100,000 person‐years in 2000 to 700.5 per 100,000 person‐years in 2020 (ABPC = −1.63, 95% CI: −2.88, −0.36; p = 0.02).

Conversely, a decreasing trend for SD-attributable mortality was observed in Western Europe [AAPC: −2.6% (95% CI: −2.1 to −0.1), p = 0.02] while it plateaued in Northern Europe [AAPC: −2.0% (95% CI: −4.7 to 0.8), p = 0.15].

A case-to-case analysis revealed a decreasing trend in the operative time (r = -0.7, p = 0.02) and CT radiation exposure (r = -0.7, p = 0.02) over time.

The MBG levels displayed a decreasing trend in the whole population after surgery ( p = 0.02).

Temporal trend A stationary trend in the incidence rate was observed (APC = 0.61, p = 0.763) for the total outbreaks, whereas a decreasing trend was noted for outbreaks with known etiological agents (APC=-4.35, p = 0.020) (Fig. 5 ).

Interestingly, a decreasing trend in NRTI TDR was also observed in LAC (4.7% vs. 3.8%, p = 0.02), possibly reflecting previous exposure to mono- or dual therapy and the consequent introduction of more potent ART schemes.

GVHD Univariate analysis showed that day 100 incidence of aGVHD grade II-IV was most prevalent in the Other cohort at 35.9%, with a decreasing trend observed among White (25.9%), South Asian (21.4%), East Asian (17.0%), and Black patients (16.3%), a statistically significant finding ( p = 0.02).

Zn1 values showed a decreasing trend across increasing dengue severity groups (p = 0.02).

Age demonstrated a decreasing trend across the tertiles (56.50 ± 8.36 years vs. 54.77 ± 9.56 years vs. 53.63 ± 11.70 years; F = 3.882, p = 0.02).

While a decreasing trend for IP-10 levels was observed in both groups, IP-10 levels remained significantly higher on day 5 (median 560 vs 212 pg/mL; p = 0.02) in the severe compared with the nonsevere group.

5 D portrays no significant trend in HbA1c in studies with a diabetes duration of <20 years (r = −0.08, p = 0.48), whereas a decreasing trend of 0.2% per decade was observed for baseline HbA1c in studies with an average disease duration of ≥20 years (r = −0.44, p = 0.02).

Overall, the proportion of total revenue (< 1.3%) toward payments to physicians and teaching hospitals remained steady except for “Direct payments,” which showed a decreasing trend ( p = 0.02) from 2015 to 2020.

BDNF outcome Changes in serum BDNF level were significantly different between the two groups ( Table 2 ), with the experimental group showing an improving trend and the control group having a decreasing trend over 6 weeks (experimental vs. control = 2088.3 pg/mL vs. -3277.4 pg/mL; group difference = 5365.6 [95% CI = 813.5–9917.8] pg/ml; p = 0.02).

Both diabetes and nondiabetes groups showed a decreasing trend in plaque erosion with age (patients with diabetes, P =0.020; patients without diabetes, P <0.001).